FELICIA MCNEIL: Open Payments
NPI 1407239262 · LUCEDALE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$183 in 10 payments from 5 companies in 2025. Trend: 2023 $249 · 2024 $260 · 2025 $183
Food & beverage: $183
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 3 | $47 |
| Alkermes, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: VRAYLAR, FANAPT, ARISTADA, Sunosi, TRINTELLIX.
Industry payments across MS — which companies pay providers there.
